Inadvertent ketamine overdose in children: clinical manifestations and outcome

S M Green1, R Clark, M A Hostetler

  • 1Departments of Emergency Medicine, Loma Linda University Medical Center and Children's Hospital, Loma Linda, CA, USA.

Annals of Emergency Medicine
|September 28, 1999
PubMed

Insights

Inadvertent ketamine overdose in children in the emergency department (ED) led to prolonged sedation and occasional respiratory depression, but no long-term adverse outcomes were observed, suggesting a wide safety margin.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Toxicology
  • Pharmacology

Background:

  • Ketamine is a widely used anesthetic and analgesic.
  • Inadvertent medication errors can occur in emergency settings.
  • Understanding the safety profile of ketamine overdose is crucial for patient management.

Purpose of the Study:

  • To characterize the clinical effects and outcomes of accidental ketamine overdose in pediatric patients presenting to the emergency department.
  • To identify the causes and patterns of ketamine dosing errors.

Main Methods:

  • A retrospective review of 9 pediatric cases of inadvertent ketamine overdose reported to the Institute for Safe Medication Practices.
  • Analysis of clinical manifestations, routes of administration, dosages, and patient outcomes.

Main Results:

  • Nine children received ketamine doses 5 to 100 times the intended amount via intramuscular or intravenous routes.
  • All patients experienced prolonged sedation (3-24 hours); 4 had transient respiratory depression requiring intervention in 2.
  • No adverse outcomes or neurological deficits were observed at discharge or follow-up.

Conclusions:

  • Inadvertent ketamine overdose in healthy children in the ED appears to have a wide margin of safety, primarily causing prolonged sedation.
  • While serious adverse events were not observed in this small sample, caution is warranted.
  • Further investigation is needed to fully understand the risks associated with ketamine overdose.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...